𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impact of cyclosporine-based immunosuppressive therapy on liver histology of hepatitis C virus–infected renal transplant patients

✍ Scribed by Leonardo L. Schiavon; Roberto J. Carvalho-Filho; Janaína L. Narciso-Schiavon; Denize V. Barbosa; Valéria P. Lanzoni; Maria Lucia G. Ferraz; Antonio Eduardo B. Silva


Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
65 KB
Volume
48
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Impact of tacrolimus versus cyclosporine
✍ Paul Martin; Ronald W. Busuttil; Robert M. Goldstein; Jeffrey S. Crippin; Goran 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 2 views

Hepatitis C virus (HCV)-induced cirrhosis is the commonest indication for orthotopic liver transplantation, but HCV recurrence is nearly universal and may worsen patient / graft outcomes. The frequency and severity of HCV recurrence has apparently increased in recent years, raising concern about a p

Long-term histological effects of preemp
✍ Alexander Kuo; Vivian Tan; Billy Lan; Mandana Khalili; Sandy Feng; John P. Rober 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB

The long-term effects of preemptive antiviral therapy on fibrosis progression in liver transplant recipients with hepatitis C virus (HCV) were examined in a cohort of consecutive liver transplant recipients who received preemptive antiviral therapy for 48 weeks (95% were virologic nonresponders). Co

Clinical outcome of patients infected wi
✍ Casavilla, F. Adrian ;Rakela, Jorge ;Kapur, Sandip ;Irish, William ;McMichael, J 📂 Article 📅 1998 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 100 KB 👁 1 views

The outcome of hepatitis C virus (HCV) infection on patient and graft survival after orthotopic liver transplantation (OLT) has been controversial. An earlier experience with a higher dose of tacrolimus (H0.1 mg/kg/d intravenously and H0.2 mg/ kg/d orally) was associated with a worse clinical outcom

Impact of highly active antiretroviral t
✍ Mark A. Winters; Aarthi Chary; Robert Eison; David Asmuth; Mark Holodniy 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 1 views

## Abstract Many hepatitis C virus (HCV)‐infected patients are also infected with HIV, and undergo antiretroviral (ARV) treatment for their human immunodeficiency virus (HIV) infection. Due to changes in HIV burden and immunologic status, HIV ARV treatment may have indirect effects on the HCV popul

Impact of immunosuppression without ster
✍ Laura Lladó; Joan Fabregat; Jose Castellote; Emilio Ramos; Xavier Xiol; Jaume To 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 296 KB 👁 2 views

The purpose of this study was to evaluate the influence of a steroid-free immunosuppression on hepatitis C virus (HCV) recurrence. A total of 198 liver transplantation (LT) patients were randomized to receive immunosuppression with basiliximab and cyclosporine, either with prednisone (steroid [St] g